ResMed Inc.
RMD · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,400,723 | $1,020,951 | $897,556 | $779,437 |
| Dep. & Amort. | $235,811 | $216,209 | $197,562 | $193,841 |
| Deferred Tax | $0 | $0 | $216 | $0 |
| Stock-Based Comp. | $91,661 | $80,184 | $71,142 | $65,257 |
| Change in WC | $16,738 | $44,784 | -$462,127 | -$708,076 |
| Other Non-Cash | $6,655 | $39,132 | -$11,050 | $20,688 |
| Operating Cash Flow | $1,751,588 | $1,401,260 | $693,299 | $351,147 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$89,865 | -$99,460 | -$134,000 | -$156,036 |
| Net Acquisitions | -$139,248 | -$133,464 | -$1,012,749 | -$42,784 |
| Inv. Purchases | -$6,416 | -$22,464 | -$32,229 | -$20,724 |
| Inv. Sales/Matur. | $0 | $1,000 | $3,937 | $6,802 |
| Other Inv. Act. | $35,484 | -$15,396 | $15,196 | -$17,176 |
| Investing Cash Flow | -$200,045 | -$269,784 | -$1,159,845 | -$229,918 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$40,000 | -$730,000 | $665,000 | $122,000 |
| Stock Issued | $74,439 | $53,094 | $49,142 | $47,384 |
| Stock Repurch. | -$300,025 | -$150,011 | $0 | $0 |
| Dividends Paid | -$310,880 | -$282,320 | -$258,276 | -$245,341 |
| Other Fin. Act. | -$29,787 | -$10,050 | -$32,992 | -$52,406 |
| Financing Cash Flow | -$606,253 | -$1,119,287 | $422,874 | -$128,363 |
| Forex Effect | $25,799 | -$1,719 | -$2,147 | -$14,434 |
| Net Chg. in Cash | $971,089 | $10,470 | -$45,819 | -$21,568 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $238,361 | $227,891 | $273,710 | $295,278 |
| End Cash | $1,209,450 | $238,361 | $227,891 | $273,710 |
| Free Cash Flow | $1,661,723 | $1,286,404 | $559,299 | $195,111 |